Bnp Paribas Asset Management Holding S.A. Regeneron Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 532,214 shares of REGN stock, worth $260 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
532,214
Previous 511,556
4.04%
Holding current value
$260 Million
Previous $364 Million
7.37%
% of portfolio
0.91%
Previous 0.9%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.59 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.12 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.76 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.34 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.95 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $52.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...